ENETS Abstract Search
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers
Introduction: ENETS requires Centers of Excellence to discuss all new gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients in a multidisciplinary tumor board (MDT) but the true value of the MDT has never been assessed
Aim(s): To assess the value of MDTs in expert centers by quantifying the change in diagnoses, additional biomarkers, radiology and treatment of patients with a suspected GEP-NET
Materials and methods: newly referred patients discussed by the MDT were prospectively included from April 1st to October 1st 2017, from seven European expert centers. The referral letter was reviewed for histopathological diagnosis, biomarkers and imaging according to ENETS guidelines. Changes in these parameters post-MDT were assessed. The study was developed by the "Knowledge NETwork"
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Zandee W
To read the full abstract, please log into your ENETS Member account.